Abstract:Author(s): Fares-Frederickson, Nancy | Advisor(s): David, Michael | Abstract: Interferon regulatory factor 3 (IRF3) is a transcription factor found in the cytoplasm of most nucleated cells. Upon pathogen detection by pattern recognition receptors, IRF3 becomes activated and translocates to the nucleus where it mediates the production of type I interferon (IFN) and IFN-stimulated genes. The collective actions of these genes induce an antimicrobial state within infected and neighboring cells, allowing for pathogen clearance. Whereas the type I IFN system has been studied extensively in the context of pathogen responses, it has more recently become appreciated for its role in immune cell modulation. In this report we discuss novel findings highlighting the involvement of the type I IFN system—with a focus on IRF3—in T cell development, activation, differentiation, and cytokine production.Using a combination of in vitro assays and in vivo disease models, we demonstrate that IRF3 is a positive regulator of lL-17 and IFN-γ in CD4+ T cells. We show that IRF3-deficient CD4+ T cells have impaired production of the pro-inflammatory cytokines IL-17 and IFN-γ, and are unable to induce disease in the T cell transfer model of colitis. Unexpectedly, we observed IRF3 nuclear translocation in activated T cells. To our knowledge, this is the first description of IRF3 activation following T cell receptor stimulation. These results, which are the focus of chapter 1, reveal a previously unappreciated role for IRF3 in CD4+ T cell responses and extend its role beyond the innate immune response to pathogens.Additionally, we show that type I IFN limits T cell production of IL-2—a cytokine required for T cell activation and expansion—by indirectly altering histone modifications in the IL-2 promoter to retain the locus in an inaccessible configuration. These results, which are the focus of chapter 2, help explain why type I IFN has been an effective treatment for multiple sclerosis—a T cell- mediated autoimmune condition.

Revisiting the role of IRF3 in inflammation and immunity by conditional and specifically targeted gene ablation in mice

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

IRF3 inhibits inflammatory signaling pathways in macrophages to prevent viral pathogenesis

Elucidating the contribution of IRF3 to effector and memory cytotoxic T cell responses after influenza virus infection

Beyond innate immunity: the role of interferon regulatory factor 3 in CD4+ T cell function (IRM15P.462)

RIPK3 interacts with MAVS to regulate type I IFN-mediated immunity to Influenza A virus infection

IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation

Author Correction: IRF3 Prevents Colorectal Tumorigenesis Via Inhibiting the Nuclear Translocation of Β-Catenin

Characterization of a Novel Isoform of Murine Interferon Regulatory Factor 3

The IFN‐inducible GTPase IRGB10 Regulates Viral Replication and Inflammasome Activation During Influenza A Virus Infection in Mice

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

IRF3 inhibits IFN‐γ‐mediated restriction of intracellular pathogens in macrophages independently of IFNAR

Functional characterization of irf3 against viral hemorrhagic septicemia virus infection using a CRISPR/Cas9-mediated zebrafish knockout model

A novel mouse model of conditional IRAK-M deficiency in myeloid cells: application in lung Pseudomonas aeruginosa infection

Enhanced TLR-induced NF-κB Signaling and Type I Interferon Responses in NLRC5 Deficient Mice

Cell Type-Specific Function of TRAF2 and TRAF3 in Regulating Type I IFN Induction

Identification of Novel Alternative Splicing Variants of Interferon Regulatory Factor 3.

Beyond Innate Immunity: Defining a Role for Interferon Regulatory Factor 3 in CD4+ T Cell Responses

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer’s disease

Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease